tiprankstipranks
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
US Market

Lexeo Therapeutics, Inc. (LXEO) Financial Statements

Compare
115 Followers

Lexeo Therapeutics, Inc. Financial Overview

Lexeo Therapeutics, Inc.'s market cap is currently $133.26M. The company's EPS TTM is $-2.842; its P/E ratio is ―; Lexeo Therapeutics, Inc. is scheduled to report earnings on March 17, 2025, and the estimated EPS forecast is $-0.81. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 654.00K$ 1.66M$ 518.48K
Gross Profit$ -1.84M$ -491.00K$ 1.64M$ 518.48K
Operating Income$ -68.51M$ -60.51M$ -50.64M$ -4.59M
EBITDA$ -66.67M$ -58.04M$ -50.62M$ -4.58M
Net Income$ -66.39M$ -59.28M$ -50.62M$ -5.15M
Balance Sheet
Cash & Short-Term Investments$ 121.47M$ 77.33M$ 135.86M$ 29.37M
Total Assets$ 139.81M$ 97.08M$ 136.86M$ 29.41M
Total Debt$ 11.64M$ 13.48M$ 0.00$ 3.01M
Net Debt$ -109.83M$ -63.85M$ -135.86M$ -26.36M
Total Liabilities$ 26.27M$ 210.03M$ 192.46M$ 34.95M
Stockholders' Equity$ 113.53M$ -112.95M$ -55.60M$ -5.54M
Cash Flow
Free Cash Flow$ -59.66M$ -55.46M$ -44.37M$ -3.13M
Operating Cash Flow$ -59.50M$ -54.56M$ -44.18M$ -3.13M
Investing Cash Flow$ -165.00K$ -901.00K$ -188.00K$ 0.00
Financing Cash Flow$ 103.79M$ 189.00K$ 150.86M$ 32.38M
Currency in USD

Lexeo Therapeutics, Inc. Earnings and Revenue History

Lexeo Therapeutics, Inc. Debt to Assets

Lexeo Therapeutics, Inc. Cash Flow

Lexeo Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis